Join our mailing list!
(Your shopping cart is empty)
Diane Publishing Books
FDA’s Review Process for New Drug Applications: A Management Review
Janet Rehnquist (ed). This report by the Office of Inspector General, Dept. of Health & Human Services, assesses how well the Food & Drug Admin. (FDA) manages its new drug application review process. The FDA receives new drug applications (NDAs) from sponsors, typically pharmaceutical companies, & reviews these applications for scientific evidence pertaining to the safety & efficacy of drugs. Based on its assessments, the FDA determines whether drugs can be marketed in the U.S. This inquiry focuses on FDA’s Center for Drug Evaluation & Research (CDER), which reviews NDAs. This inquiry does not assess the scientific merit of the decisions that FDA has made. Instead, it examines how well FDA carries out its NDA review process. Illustrations.
Country Ribbon Crafts: Delightful Projects Using Easy Techniques
Essential Tibetan Buddhism
Commonwealth of Science: ANZAAS & the Scientific Enterprise in Australia, 1888-1988
Solutions: The Woman’s Crisis Handbook
Women of Strength: Biographies of 106 Who Have Excelled in Traditionally Male Fields, A.D. 61 to the Present
Share your knowledge of this product with other customers...
Be the first to write a review
Diane Publishing Co
PO Box 617
Darby, PA 19023-0617
Become an Affiliate
Send Us Feedback
Copyright ï¿½ 2004 Diane Publishing Company. All Rights Reserved.